Cargando…
USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
Abnormal alternative splicing (AS) caused by alterations in spliceosomal factors is implicated in cancers. Standard models posit that splice site selection is mainly determined by early spliceosomal U1 and U2 snRNPs. Whether and how other mid/late-acting spliceosome components such as USP39 modulate...
Autores principales: | Zheng, Jingyi, Wu, Shasha, Tang, Mao, Xi, Shaoyan, Wang, Yanchen, Ren, Jun, Luo, Hao, Hu, Pengchao, Sun, Liangzhan, Du, Yuyang, Yang, Hui, Wang, Fenfen, Gao, Han, Dai, Ziwei, Ou, Xijun, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567755/ https://www.ncbi.nlm.nih.gov/pubmed/37821439 http://dx.doi.org/10.1038/s41419-023-06210-3 |
Ejemplares similares
-
UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
por: Wang, Yanchen, et al.
Publicado: (2023) -
USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
por: Das, Tanuza, et al.
Publicado: (2022) -
USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1
por: Pan, Xiu-wu, et al.
Publicado: (2021) -
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2
por: Wang, Shourong, et al.
Publicado: (2021) -
The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor
por: Zhu, Xiaolin, et al.
Publicado: (2022)